AzTrials
AzTrials

Muscle ActivationNCT04312529

Analysis of Shoulder Muscle Activity During Isokinetic Evaluation of Rotators

A study testing Isokinetic test + EMG in people with Muscle Activation and Electromyography, run by University of Liege at 1 site in Belgium.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The objective of this study is to assess the impact of different positions of the glenohumeral joint on the maximum muscle contraction of different shoulder muscles. The muscles do not contract with the same intensity depending on the position of the arm in relation to the trunk. Read more about this study

Who is it for?
Ages 18 to 35 years, men onlyHealthy volunteers can take part
What is being tested?
Isokinetic test + EMG
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteBelgium
Study dates
1 Nov 2020to May 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Male subjects aged 18-35.
  • Playing a sport using the upper limb (handball, volleyball, swimming, tennis) at least 6h/week

Who cannot join

  • Pain in the shoulder
  • Shoulder pathologies such as gleno-humeral dislocation, tendinopathy, sub-acromial conflict, etc.
  • History of shoulder surgery (prosthesis, stabilizing surgery, etc.)

Trial locations and contacts

1 site in 1 country.

Amandine Gofflot contact

+3243662193

agofflot@uliege.be

Belgium1 site, 1 recruiting
  • Université de Liège

    Liège, 4000

    Amandine Gofflot, +3243662193

    Recruiting

Other trials in Belgium

About this study

The objective of this study is to assess the impact of different positions of the glenohumeral joint on the maximum muscle contraction of different shoulder muscles. The muscles do not contract with the same intensity depending on the position of the arm in relation to the trunk. With the determination of this optimal position to activate the shoulder muscles as much as possible, we will be able to strengthen the patients during their revalidation.

Being tested
Isokinetic test + EMG

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Isokinetic test + EMGOther

    Isokinetic test:The isokinetic device is used to evaluate the strength of a subject. The test will be performed in two positions. This will determine the best position to activate shoulder muscles EMG (electromyography):it's a device that measures the electrical activity of muscles. This will allow us to record the maximum activity of the shoulder muscles during force tests.

Study groups in NCT04312529
Study groupRoleWhat they receive
Overhead athletesExperimentalNot described
Receives: Other: Isokinetic test + EMG

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. strength test

    The strength will be assess with a isokinetic device. It will allow to calculate the maximum force of the subject at the level of the rotators of the shoulder. This is a dorsal decubitus test. The subject's arm will be positioned during one session in 45° of abduction and the other session in 90° of shoulder abduction.

    In this position, the subject will perform tests at different speeds (60°/s concentric, 240°/s concentric and 60°/s eccentric). This will calculate the maximum force.

    Measured: Day 1.

  2. Electrical activity of the muscles

    The electromyography will allow to calculate the electrical activity of the muscles during the two isokinetics and thus to determine which active position the most the muscles of the shoulder. This measurement is achieved by the installation of surface electrodes

    Measured: Day 1.

Secondary outcomes (1)
  1. Weight

    We will ask the weight of the subject to calculate his relative strength

    Measured: Day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Mar 2020
  2. Study start1 Nov 2020
  3. Primary completion24 Dec 2020
  4. Study completionMay 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Screening
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04312529
Sponsor's protocol ID
1996
Status last verified
May 2023
First submitted
11 Mar 2020
Last updated
9 May 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Isokinetic test + EMG in people with Muscle Activation and Electromyography, run by University of Liege at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 May 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Amandine Gofflot (+3243662193, agofflot@uliege.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

strength test (time frame: Day 1.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 May 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in